Fig. 6From: Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cellsMolecular transition of sherbet like aggregates attaching to mesothelium. a H&E image of peritoneal mass from Amatuximab treated mice. b Immunohistochemistry of the indicated proteins. c Immunohistochemistry of the indicated proteins shown on the left; the frequencies of positive stained cells in each treatment group were calculated and shown on the right. Arrows indicate the representative image of the positively stained cells *P < 0.05. Scale bar, 100 μmBack to article page